Clinical Trial Update: To Investigate the Effects of AZD1981 on the QT Interval [Phase 1]

View source ↗

Summary

This clinical trials update notes the completion of a Phase 1 study assessing the effect of AZD1981 on the QT interval in individuals with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD1981

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED